Figure S1. mRNA expression of methyltransferases and demethylases in OS cells with or without cisplatin treatment. (TIF 1114 kb
ST6Gal-I mRNA expression levels after transfection for different time points analyzed in this study....
Table (S3). Association between different parameters and histological response in osteosarcoma patie...
MTT assay of combination of RTK inhibitors with cisplatin. Influence of 48 h preincubation with 1.5 ...
Figure S4. Upregulation of H3K27me3 levels sensitizes OS to cisplatin. Colony formation ability of O...
Figure S3. Knockdown of KDM6A or KDM6B enhances cisplatin-induced apoptosis in OS cells. Cleaved Cas...
Figure S2. Knockdown efficacy of KDM6A and KDM6B as measured by western blot analysis. (TIF 217 kb
Figure S5. Overexpression of PRKCA reverses the chemosensitization effects of GSK-J4 with regards to...
List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of pr...
Characterization of MDA-MB231 and cisplatin-resistant MDA-MB231CisR. MDA-MB231 and cisplatin-resista...
Table S2. Changes in protein expression levels for each studied cancer stem cell marker following tr...
NF-κB escalated PIK3CA promoter activity in SP cells. Cisplatin and TNFα but not lithium chloride or...
Figure S1. The effects of Fn14 on cisplatin-resistance in HGSOC cells. (A)-(D) Statistical data of W...
Figure S1. ETS-1 is important for cisplatin sensitive HNSCC cell proliferation. Figure S2. ETS-1 is ...
Figure S3. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(D) ...
Cisplatin induced NF-κB and its physical interaction with PIK3CA promoter in TOV21G and SKOV3 cells....
ST6Gal-I mRNA expression levels after transfection for different time points analyzed in this study....
Table (S3). Association between different parameters and histological response in osteosarcoma patie...
MTT assay of combination of RTK inhibitors with cisplatin. Influence of 48 h preincubation with 1.5 ...
Figure S4. Upregulation of H3K27me3 levels sensitizes OS to cisplatin. Colony formation ability of O...
Figure S3. Knockdown of KDM6A or KDM6B enhances cisplatin-induced apoptosis in OS cells. Cleaved Cas...
Figure S2. Knockdown efficacy of KDM6A and KDM6B as measured by western blot analysis. (TIF 217 kb
Figure S5. Overexpression of PRKCA reverses the chemosensitization effects of GSK-J4 with regards to...
List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of pr...
Characterization of MDA-MB231 and cisplatin-resistant MDA-MB231CisR. MDA-MB231 and cisplatin-resista...
Table S2. Changes in protein expression levels for each studied cancer stem cell marker following tr...
NF-κB escalated PIK3CA promoter activity in SP cells. Cisplatin and TNFα but not lithium chloride or...
Figure S1. The effects of Fn14 on cisplatin-resistance in HGSOC cells. (A)-(D) Statistical data of W...
Figure S1. ETS-1 is important for cisplatin sensitive HNSCC cell proliferation. Figure S2. ETS-1 is ...
Figure S3. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(D) ...
Cisplatin induced NF-κB and its physical interaction with PIK3CA promoter in TOV21G and SKOV3 cells....
ST6Gal-I mRNA expression levels after transfection for different time points analyzed in this study....
Table (S3). Association between different parameters and histological response in osteosarcoma patie...
MTT assay of combination of RTK inhibitors with cisplatin. Influence of 48 h preincubation with 1.5 ...
DOI
Add to ORKG